
Alpha Profiles · Company Profile
Caribou Biosciences, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/caribou-biosciences-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: CRBU
- Verification
- Partially verified
- Last reviewed
- 2026-10-17T04:46:59.013572+00:00
Overview
Alpha's canonical identity and public leadership record for Caribou Biosciences, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
6 public recordsChief Legal Officer and Corporate Secretary
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- CRBU DEF 14A executive officersApr 24, 2026
President and Chief Executive Officer
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- CRBU DEF 14A executive officersApr 24, 2026
Chief Business Officer
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- CRBU DEF 14A executive officersApr 24, 2026
Chief Financial Officer
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- CRBU DEF 14A executive officersApr 24, 2026
Chief Technology Officer
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- CRBU DEF 14A executive officersApr 24, 2026
Chief Medical Officer
- State
- confirmed
- Effective
- From Apr 24, 2026
- Confidence
- 94%
- Evidence
- CRBU DEF 14A executive officersApr 24, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
8 public records- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2011
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Caribou Biosciences, Inc. DEF 14A 2026-04-24Apr 24, 2026
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Andrew Guggenhime
- Members
- Andrew Guggenhime (Chair); David Johnson; Scott Braunstein
Compensation
- Chair
- Scott Braunstein
- Members
- Scott Braunstein (Chair); Andrew Guggenhime; Nancy Whiting
Nominating and Governance
- Chair
- Natalie Sacks
- Members
- Natalie Sacks (Chair); Dara Richardson-Heron; Ran Zheng
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-17T04:46:59.013572+00:00



